ATLANTA and CINCINNATI, Aug. 21, 2012 /PRNewswire/ -- Streamline Health Solutions, Inc. (NASDAQ CM: STRM, www.streamlinehealth.net), a leading provider of enterprise content management and business analytics solutions for healthcare organizations, today announced that on March 24, 2011, James Rice, In-House Legal Counsel received a grant of incentive stock options for 15,000 shares of Streamline Health common stock with an option exercise price of $1.82 per share, vesting annually over three years, and on December 7, 2011, Matthew Seefeld, Chief Strategist, Revenue Cycle, and James Skrinska, Chief Technology Officer, each received grants of incentive stock options for 100,000 shares of Streamline Health common stock with an option exercise price of $1.65, which vest ratably over 36 months. The option awards described in this paragraph are inducement grants, pursuant to NASDAQ Marketplace Rule 5635 (c) (4).

About Streamline Health
Streamline Health provides solutions that help hospitals and physician groups improve efficiencies and business processes across the enterprise to enhance and protect revenues.  Our comprehensive suite of health information solutions includes enterprise content management, business analytics, and integrated workflow systems.  Our solutions offer a flexible, customizable way to optimize the clinical and financial performance of any healthcare organization.  For more information please visit our website at http://www.streamlinehealth.net.  

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995
Statements made by Streamline Health Solutions, Inc. that are not historical facts are forward-looking statements that are subject to risks and uncertainties and are no guarantee of future performance. The forward looking statements contained herein are subject to certain risks, uncertainties and important factors that could cause actual results to differ materially from those reflected in the forward-looking statements, included herein. These risks and uncertainties include, but are not limited to, the timing of contract negotiations and execution of contracts and the related timing of the revenue recognition related thereto, the potential cancellation of existing contracts or clients not completing projects included in the backlog, the impact of competitive products and pricing, product demand and market acceptance, new product development, key strategic alliances with vendors that resell the Company's products, the ability of the Company to control costs, availability of products obtained from third party vendors, the healthcare regulatory environment, potential changes in legislation, regulation and government funding affecting the healthcare industry, healthcare information systems budgets, availability of healthcare information systems trained personnel for implementation of new systems, as well as maintenance of legacy systems, fluctuations in operating results, effects of critical accounting policies and judgments, changes in accounting policies or procedures as may be required by the Financial Accountings Standards Board or other similar entities, changes in economic, business and market conditions impacting the healthcare industry, the markets in which the Company operates and nationally, and the Company's ability to maintain compliance with the terms of its credit facilities, and other risks detailed from time to time in the Streamline Health Solutions, Inc. filings with the U. S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's analysis only as of the date hereof. The Company undertakes no obligation to publicly release the results of any revision to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

SOURCE Streamline Health Solutions, Inc.